BackgroundCheck.run
Search For

William N Haining, 56100 Homer St, Newton, MA 02459

Known as:
Wil N Haining Nicholas N Haining Nicholas W Haining Wnicholas Haining W Nicholas Haining
Related to:
Harriet Yunker

William Haining Phones & Addresses

100 Homer St, Newton Center, MA 02459    617-3328255   

Newton, MA   

Cambridge, MA   

Boston, MA   

Work

Position: Medical Professional

Education

Degree: Graduate or professional degree
Get Report
Control this profile

Mentions for William N Haining

Career records & work history

Medicine Doctors

William N. Haining

Specialties:
Pediatric Hematology-Oncology
Work:
Dana-Farber Cancer Institute Center For Neurology-Oncology
450 Brookline Ave FL 10, Boston, MA 02215
617-6326633 (phone) 617-6324773 (fax)
Education:
Medical School
Oxford Univ Med Sch, Oxford, Uk (352 09 Pr 1/71)
Graduated: 1992
Procedures:
Lumbar Puncture
Conditions:
Anemia, Hodgkin's Lymphoma, Leukemia, Abdominal Hernia, Anxiety Phobic Disorders, Hemolytic Anemia
Languages:
Chinese, English, French, Spanish
Description:
Dr. Haining graduated from the Oxford Univ Med Sch, Oxford, Uk (352 09 Pr 1/71) in 1992. He works in Boston, MA and specializes in Pediatric Hematology-Oncology. Dr. Haining is affiliated with Boston Childrens Hospital, Brigham & Womens Hospital and MassGeneral For Children At North Shore Medical Center.

Publications & IP owners

Wikipedia

William Haining Photo 13

Will Haining

William "Will" Haining (born 2 October 1982) is a Scottish footballer. He is a central defender, and is currently playing for English League Two side, Morecambe.

Us Patents

Ph-Triggered Microparticles

US Patent:
2005012, Jun 9, 2005
Filed:
Sep 23, 2004
Appl. No.:
10/948981
Inventors:
Daniel Kohane - Newton MA, US
Daniel Anderson - Framingham MA, US
Robert Langer - Newton MA, US
William Haining - Newton MA, US
Lee Nadler - Newton MA, US
International Classification:
A61K009/127
C12N015/88
A61K048/00
A61K009/14
US Classification:
424450000, 424489000, 514044000, 435458000
Abstract:
Microparticles that are designed to release their payload when exposed to acidic conditions are provided as a vehicle for drug delivery. Any therapeutic, diagnostic, or prophylatic agent may be encapsulated in a lipid-protein-sugar or polymeric matrix including a pH triggering agent to form pH triggerable microparticles. Preferably the diameter of the pH triggered microparticles ranges from 50 nm to 10 micrometers. The matrix of the particles may be prepared using any known lipid (e.g., DPPC), protein (e.g., albumin), or sugar (e.g., lactose). The matrix of the particles may also be prepared using any synthetic polymers such as polyesters. Methods of preparing and administering the particles are provided. Methods of immunization, transfection, and gene therapy are also provided by administering pH triggerable microparticles.

Modulating Dsrna Editing, Sensing, And Metabolism To Increase Tumor Immunity And Improve The Efficacy Of Cancer Immunotherapy And/Or Modulators Of Intratumoral Interferon

US Patent:
2020037, Dec 3, 2020
Filed:
Apr 2, 2018
Appl. No.:
16/497294
Inventors:
Matthew MEYERSON - Concord MA, US
William N. HAINING - Newton MA, US
Jeffrey ISHIZUKA - Boston MA, US
Robert MANGUSO - Boston MA, US
Hugh GANNON - Groton MA, US
- Boston MA, US
International Classification:
C12N 15/11
A61K 31/712
C12Q 1/6886
Abstract:
The present invention relates, in part, to methods of treating a subject afflicted with a cancer comprising administering to the subject a therapeutically effective amount of an agent that inhibits or promotes the copy number, the expression level, and/or the activity of one or more biomarkers listed in Table 1 or a fragment thereof. Also provided herein are methods of detecting ADAR1 or ISG15 dependency in a high proliferation cell (e.g., a cancer cell). Also provided are methods of detected increased interferon signaling pathway activity in a high proliferation cell (e.g., a cancer cell). Included herein are methods of treating cancer with inhibitors of ADAR1 or ISG15. Methods of screening for such inhibitors are also provided herein. Methods of identifying the likelihood of a cancer to be responsive to an ADAR1 inhibitor are also provided.

Methods And Compositions For Perturbing Gene Expression In Hematopoietic Stem Cell Lineages In Vivo

US Patent:
2017021, Aug 3, 2017
Filed:
May 27, 2015
Appl. No.:
15/314251
Inventors:
William N. HAINING - Newton MA, US
Arlene H. SHARPE - Brookline MA, US
Jernej GODEC - Brookline MA, US
- Boston MA, US
- Cambridge MA, US
International Classification:
A01K 67/027
G01N 33/50
A61K 49/00
C12N 5/0783
C12N 5/0781
C12N 15/86
C12N 15/11
Abstract:
The invention provides methods and compositions for perturbing gene expression in hematopoietic cell lineages in vivo.

Isbn (Books And Publications)

Intraocular Lens Implantation

Author:
William M. Haining
ISBN #:
0801641683

Public records

Vehicle Records

William Haining

Address:
100 Homer St, Newton Center, MA 02459
Phone:
617-3328255
VIN:
JHLRE48377C031420
Make:
HONDA
Model:
CR-V
Year:
2007

Possible Relatives

David W Haining  Debra A Haining  James H Haining  Jin C Haining  Shane J Haining  William V Johnson  William D Stamps  William N Stanberry  William E Stanbery  William D Stanbro 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.